Induction of complete remission using single agent clofarabine in a patient with primary refractory acute myeloblaste leukemia.
Refractory AML patients have a very poor prognosis. Therefore, rationally designed new therapies, including clofarabine, are being investigated as potential treatments for this patient population. This is a case report of a patient with primary refractory AML who was treated with clofarabine and achieved a complete response.